Back HIV/AIDS

HIV / AIDS

New HIV PrEP Studies Will Be a Challenge, Statisticians Warn

Two statisticians involved in the PROUD and iPrEx trials of HIV pre-exposure prophylaxis (PrEP) warn that future trials to test new PrEP drugs and formulations may be extremely difficult to design. David Dunn of the UK Medical Research Council and David Glidden of the University of California at San Francisco say that statisticians will need to choose and analyze their trial populations very carefully if they wish to be able to demonstrate meaningful results.

alt

Conference on Retroviruses and Opportunistic Infections Starts Next Week in Boston

The 2016 Conference on Retroviruses and Opportunistic Infections (CROI) will take place next week, February 22-25, at the Hynes Convention Center in Boston. Starting Monday, HIVandHepatitis.com and our partners at Aidsmap will provide on-site coverage of HIV pre-exposure prophylaxis (PrEP), new HIV treatments, and more.

alt

Health Officials Urge Broader PrEP Use After 4 More HIV Cases Found in Indiana County

An additional 4 new cases of HIV in rural Scott County -- bringing the total to 188 -- have prompted the Indiana State Department of Health to urge people at risk for infection to talk to their healthcare providers about pre-exposure prophylaxis or PrEP, according to a recent announcement.

alt

NHPC 2015: High Rates of HIV Found Among Trans Women

Although transgender people -- especially trans women of color -- have among the higher rates of HIV infection, this population has not been adequately studied. Many HIV prevention studies have miscategorized transgender women as men who have sex with men, and there has been little specific research on HIV among trans men.

alt

Meta-Analysis Shows Women Are Under-Represented in HIV Clinical Trials

Less than a quarter of people taking part in clinical trials for antiretroviral medications are women, potentially limiting the generalizability of findings, according to a systematic review published in the February 1 edition of the Journal of Acquired Immune Deficiency Syndromes.

alt

PrEP Use Rising Among High-Risk Gay Men in Washington State

More than 20% of gay and bisexual men in Washington State considered to be at high risk for HIV infection were taking Truvada pre-exposure prophylaxis (PrEP) in 2015, and a large majority of both higher- and lower-risk men were aware of it, according to a study published in the January 28 edition of AIDS.

alt

HIV Medicine Association Cautions Against Excessive HIV-Related Testing

The HIV Medicine Association (HIVMA) has released new recommendations calling on HIV care providers to avoid routine use of unnecessary monitoring tests, including frequent CD4 T-cell counts and viral load tests for people on stable suppressive antiretroviral therapy.

alt